<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>MEDIHALER ERGOTAMINE- ergotamine tartrateÂ aerosol, meteredÂ </strong><br>3M Riker<br></p></div>
<h1>Medihaler Ergotamine<span class="Sup">Â®</span><br>(ergotamine tartrate)</h1>
<div class="Contents">
<div class="Section">
<a name="dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s1"></a><a name="section-2"></a><p></p>
<h1>PHARMACIST:</h1>
<p class="First">Tear off â€œInstructions for Useâ€? and dispense with container in carton.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s3"></a><a name="section-3"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">MEDIHALER ERGOTAMINE (ergotamine tartrate) is an oral aerosol device which contains a fine particle suspension of 9.0 mg ergotamine tartrate per ml in an insert, nontoxic aerosol vehicle.  The inert ingredients are dichlorodifluoromethane, dichlorotetrafluoroethane, sorbitan trioleate and trichloromonofluoromethane.  Each <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of the valve delivers a measured dose of 0.36 mg to the patient.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s4"></a><a name="section-4"></a><p></p>
<h1>ACTION</h1>
<p class="First">Ergotamine exerts a constrictor action upon cranial vessels.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s5"></a><a name="section-5"></a><p></p>
<h1>INDICATIONS</h1>
<p class="First">As therapy to abort <span class="product-label-link" type="condition" conceptid="4134454" conceptname="Vascular headache">vascular headache</span>, e.g., <span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">migraine</span>, <span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">migraine</span> variants, or so-called â€œhistaminic cephalalgia.â€?</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s6"></a><a name="section-6"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Ergotamine tartrate should not be used in the presence of <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span>, <span class="product-label-link" type="condition" conceptid="321052" conceptname="Peripheral vascular disease">peripheral vascular disease</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, impaired renal or hepatic function, infectious states or <span class="product-label-link" type="condition" conceptid="4090739" conceptname="Nutritional disorder">malnutrition</span>.</p>
<p>Ergotamine tartrate is contraindicated in patients with a history of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span>.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s7"></a><a name="section-6.1"></a><p></p>
<p class="First"><span class="Bold">Pregnancy:</span> Ergotamine tartrate is contraindicated in pregnancy.</p>
</div>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s8"></a><a name="section-7"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Patients who are being treated with MEDIHALER ERGOTAMINE should be informed adequately of the symptoms of <span class="product-label-link" type="condition" conceptid="4201303" conceptname="Ergotism">ergotism</span>.  Close medical supervision by the physician is recommended so that he may react appropriately should signs of <span class="product-label-link" type="condition" conceptid="4201303" conceptname="Ergotism">ergotism</span> develop.  Six inhalations per day, if continued daily, entail the risk of vasospastic complications.  Avoid prolonged administration or in excess of the recommended dosage because of the danger of <span class="product-label-link" type="condition" conceptid="4201303" conceptname="Ergotism">ergotism</span> and <span class="product-label-link" type="condition" conceptid="439928" conceptname="Gangrenous disorder">gangrene</span>.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="s9"></a><a name="section-7.1"></a><p></p>
<p class="First"><span class="Bold">Pediatric Patients</span>: Since there is no experience in children who have received this drug, safety and efficacy in children have not been established.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s10"></a><a name="section-7.2"></a><p></p>
<p class="First"><span class="Bold">Nursing Mothers:</span> Whether ergotamine tartrate is excreted in mothers' milk is not known.  As a general rule, nursing should not be undertaken while a patient is on a drug (since many drugs are excreted in human milk).</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s11"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Ergotamine tartrate may cause <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>.  Patients with <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span> may become <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nauseated</span> and drug induced distress may be difficult to evaluate.</p>
<p>Ergotamine in large doses raises arterial pressure, produces coronary <span class="product-label-link" type="condition" conceptid="4137788" conceptname="Vascular constriction">vasoconstriction</span> and slows the heart both by direct action and its effect on the vagus.  Under this condition, ergotamine also has oxytocic and spasmolytic properties.  The above conditions are seen as a consequence of overdosage and may be manifested at the dosage recommended for control of <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>.</p>
<p>Vasoconstrictive complications, at times of a serious nature, may occur.  These include <span class="product-label-link" type="condition" conceptid="4117262" conceptname="Peripheral pulse absent">pulselessness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">muscle pains</span> and <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span> of the extremities and precordial distress and <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>.  Although these effects occur most commonly with long term therapy at relatively high doses, they have also been reported with short term or normal doses.  Other adverse effects include transient <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span> or <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="4026047" conceptname="Sacral edema">localized edema</span> and <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s12"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s13"></a><a name="section-9.1"></a><p></p>
<p class="First"><span class="Bold">Adults:</span> A single oral inhalation at the first sign of a <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span> or prodrome.  Repeat this procedure in 5 minutes if relief is not obtained.  Space and additional inhalations at no less than 5-minute intervals.  No more than 6 inhalations should be administered in any 24-hour period, and no more than 15 in a one week period.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s14"></a><a name="section-9.2"></a><p></p>
<p class="First"><span class="Bold">Children:</span> A recommended dose for children has not been determined.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s15"></a><a name="section-10"></a><p></p>
<h1>DIRECTIONS FOR USE:</h1>
<p class="First">Before each use, remove dust cap and shake MEDIHALER ERGOTAMINE.</p>
<ol class="Arabic">
<li>Breathe out fully and place mouthpiece well into the mouth, aimed at the back of the throat.</li>
<li>As you begin to breathe in deeply, press the vial firmly down into the adapter with the index finger.  This releases one dose.</li>
<li>Release pressure on the vial and remove unit from mouth.  Hold the breath as long as possible, then breathe out slowly.</li>
</ol>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s16"></a><a name="section-11"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Metal vial (2.5 ml) and adapter.  Each <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of the valve delivers 0.36 mg ergotamine tartrate.</p>
<p>(NDC <span class="Bold">0089-0762-21</span>)</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="e16"></a><a name="section-12"></a><p></p>
<h1>CAUTION</h1>
<p class="First">Federal law prohibits dispensing without prescription.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="e17"></a><a name="section-13"></a><p></p>
<h1>CONTENTS UNDER PRESSURE</h1>
<p class="First">Do not puncture or incinerate container.  Do not expose to heat or store at temperatures above 120Â°F.  KEEP OUT OF THE REACH OF CHILDREN.</p>
<p>3M Riker<br>3M Health Care<br>Northridge, CA 91324</p>
<p>ERG-16</p>
<p>JUNE 1989</p>
</div>
<div class="Section" data-sectionCode="38056-8">
<a name="e18"></a><a name="section-14"></a><p></p>
<div class="Section" data-sectionCode="42230-3">
<a name="s17"></a><a name="section-14.1"></a><p></p>
<h2>INSTRUCTIONS FOR USE OF</h2>
<p class="First"><span class="Bold">Medihaler Ergotamine</span><span class="Sup">Â®</span></p>
<p>(ergotamine tartrate)</p>
<p><span class="Bold">FOR ORAL INHALATION THERAPY ONLY</span></p>
<p>SHAKE WELL before each use.</p>
<p>To get the medication deep into lungs, follow these five simple steps. (can be completed within 5 seconds):</p>
<ol class="Arabic">
<li>Remove dust cap and inspect mouthpiece for dirt and foreign objects.</li>
<li>Empty the lungs as completely as possible by exhaling, and insert open end of plastic mouthpiece into mouth.</li>
<li>After beginning to inhale deeply, press the top of the metal vial downward, as you would a push-button; this releases one measured dose of the medication.  Complete taking the deep breath, which draws medication into your lungs.</li>
<li>Remove mouthpiece and hold breath for as long as possible.  This distributes the medication in the lungs</li>
<li>Exhale slowly, keeping the lips nearly closed.</li>
</ol>
<p>Start with one inhalation â€“ then wait five minutes; if not relieved, use MEDIHALER ERGOTAMINE again.  Any additional inhalations should be spaced at intervals of no less than five minutes.  Take no more than six inhalations in any 24-hour period, and no more than 15 in a one-week period.  MEDIHALER ERGOTAMINE was designed to deliver a full dose for most people in one or two inhalations.  Do not use MEDIHALER ERGOTAMINE indiscriminately; use only the number of inhalations actually required for relief.</p>
<p>The oral adapter (plastic mouthpiece) should be kept clean.  Simply remove metal vial and wash oral adapter with soap and hot water and rinse thoroughly.  Dry and replace the vial and the dust cap.</p>
<p><span class="Bold">WARNING: CONTENTS UNDER PRESSURE.</span></p>
<p>Do not puncture or incinerate container.  Do not expose to heat or store at temperatures above 120Â°F.  Keep out of the reach of children.</p>
<p><span class="Bold">Medihaler Ergotamine</span><span class="Sup">Â®</span></p>
<p>(ergotamine tartrate)</p>
<div class="Figure">
<a name="f1"></a><img alt="Image from Drug Label Content" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e713859d-f454-4f7e-a535-868b8d5f2c88&amp;name=medihaler-ergotamine-01.jpg">
</div>
<p>For speed of relief and convenience the MEDIHALER ERGOTAMINE oral inhaler comes ready-to-use.  It consists of two parts:</p>
<ol class="BigAlpha">
<li>A metal vial, containing the medication, with a single dose valve, which fits into</li>
<li>The oral adapter (plastic mouthpiece) with dust cap.  The vial can be used only with MEDIHALER ERGOTAMINE oral adapter.</li>
</ol>
<p><span class="Bold">ADVANTAGES:</span></p>
<ul class="Disc">
<li><span class="Bold">Provides relief with seconds</span></li>
<li><span class="Bold">Assures a uniform, measured dose with each <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> of the vial</span></li>
<li><span class="Bold">Economical; all the medication is utilized; no loss or waste</span></li>
</ul>
<p>3M Riker<br>3M Health Care<br>Northridge, CA 91324</p>
<p>JUNE 1989</p>
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>MEDIHALER ERGOTAMINEÂ 		
					</strong><br><span class="contentTableReg">ergotamine tartrate aerosol, metered</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0089-0762</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ergotamine tartrate</strong> (ergotamine) </td>
<td class="formItem"></td>
<td class="formItem">9.0Â mg Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>dichlorodifluoromethane</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>dichlorotetrafluoroethane</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sorbitan trioleate</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>trichloromonofluoromethane</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0089-0762-21</td>
<td class="formItem">2.5 mL in 1 INHALER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>3M Riker</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 7/2006<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>e713859d-f454-4f7e-a535-868b8d5f2c88</div>
<div>Set id: e713859d-f454-4f7e-a535-868b8d5f2c88</div>
<div>Version: 1</div>
<div>Effective Time: 20060713</div>
</div>
</div>Â <div class="DistributorName">3M Riker</div></p>
</body></html>
